| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9844 |
| Human Intestinal Absorption | HIA+ | 0.9852 |
| Caco-2 Permeability | Caco2+ | 0.8203 |
| P-glycoprotein Substrate | Substrate | 0.8092 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8563 |
| Inhibitor | 0.8570 |
| Renal Organic Cation Transporter | Inhibitor | 0.7087 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4659 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7438 |
| CYP450 2D6 Substrate | Substrate | 0.8618 |
| CYP450 3A4 Substrate | Substrate | 0.6468 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9106 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9319 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.9115 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9105 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7333 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9537 |
| Inhibitor | 0.7813 |
| AMES Toxicity | Non AMES toxic | 0.8490 |
| Carcinogens | Non-carcinogens | 0.9292 |
| Fish Toxicity | High FHMT | 0.6477 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.6541 |
| Honey Bee Toxicity | Low HBT | 0.7401 |
| Biodegradation | Not ready biodegradable | 0.9829 |
| Acute Oral Toxicity | III | 0.7696 |
| Carcinogenicity (Three-class) | Non-required | 0.7124 |